アステラス製薬株式会社 · Pharmaceutical · FY ends Mar
| # | Shareholder | Shares | Stake | Value | Dividends |
|---|---|---|---|---|---|
| 1 | 日本マスタートラスト信託銀行株式会社 | 343,200,000 | 18.96% | ¥867B | ¥26.8B |
| 2 | 株式会社日本カストディ銀行 | 130,182,000 | 7.19% | ¥329B | ¥10.2B |
| 3 | 日本生命保険相互会社 | 51,588,000 | 2.85% | ¥130B | ¥4.0B |
| 4 | STATE STREET BANK AND TRUST COMPANY 505001 | 38,405,000 | 2.12% | ¥97.1B | ¥3.0B |
| 5 | JPモルガン証券株式会社 | 30,057,000 | 1.66% | ¥76.0B | ¥2.3B |
| 6 | JP MORGAN CHASE BANK 385781 | 26,465,000 | 1.46% | ¥66.9B | ¥2.1B |
| 7 | SMBC日興証券株式会社 | 22,484,000 | 1.24% | ¥56.8B | ¥1.8B |
| 8 | 野村信託銀行株式会社 | 22,218,000 | 1.22% | ¥56.2B | ¥1.7B |
| 9 | STATE STREET BANK AND TRUST COMPANY 505103 | 21,360,000 | 1.18% | ¥54.0B | ¥1.7B |
| Name | Title | Shares | Value | Pay |
|---|---|---|---|---|
| Kenji Yasukawa | Chairman & Representative Director | 245,000 | ¥619M | — |
| 岡村 直樹 | President & Representative Director | 84,000 | ¥212M | — |
| 杉田 勝好 | Executive Vice President & Representative Director | 11,000 | ¥27.8M | — |
| 田中 孝司 | Director | — | — | — |
| 桜井 恵理子 | Director | — | — | — |
| 宮﨑 正啓 | Director | 8,000 | ¥20.2M | — |
| 大野 洋一 | Director | — | — | — |
| Mark Enyedy | Director | — | — | — |
| 廣田 里香 | Director (Audit & Supervisory Committee Member) | 9,000 | ¥22.7M | — |
| 中山 美加 | Director (Audit & Supervisory Committee Member) | — | — | — |
| 秋山 里絵 | Director (Audit & Supervisory Committee Member) | — | — | — |
| 荒牧 知子 | Director (Audit & Supervisory Committee Member) | — | — | — |
Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.
| Fiscal year | Price | EPS | P/E | Dividend | Shares issued |
|---|---|---|---|---|---|
| FY ending Mar 2026 | ¥2,527 | ¥205.47 | 12.3x | ¥78.0 | 1,809,663,000 |
| FY ending Mar 2025 | ¥1,447 | ¥178.59 | 8.1x | ¥74.0 | 1,809,663,000 |
| FY ending Mar 2024 | ¥1,646 | ¥162.92 | 10.1x | ¥70.0 | 1,809,663,000 |
| FY ending Mar 2023 | ¥1,882 | ¥172.64 | 10.9x | ¥60.0 | 1,809,663,000 |
| FY ending Mar 2022 | ¥1,910 | ¥121.69 | 15.7x | ¥50.0 | 1,835,852,000 |
| FY ending Mar 2021 | ¥1,705 | ¥103.95 | 16.4x | ¥42.0 | 1,861,787,000 |
| FY ending Mar 2020 | ¥1,667 | ¥128.26 | 13.0x | ¥40.0 | 1,861,787,000 |
| FY ending Mar 2019 | ¥1,656 | ¥92.49 | 17.9x | ¥38.0 | 1,979,823,000 |
| FY ending Mar 2018 | ¥1,608 | ¥146.20 | 11.0x | ¥36.0 | 2,068,823,000 |
| FY ending Mar 2017 | ¥1,464 | ¥65.34 | 22.4x | ¥34.0 | 2,153,823,000 |